These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9098917

  • 1. Antiretroviral therapy: a guide to the most important trials.
    Rutschmann O, Hirschel B.
    Schweiz Med Wochenschr; 1997 Mar 15; 127(11):436-43. PubMed ID: 9098917
    [Abstract] [Full Text] [Related]

  • 2. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 15; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 3. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L, Bachmeyer C.
    Ann Dermatol Venereol; 1997 Aug 15; 124(9):641-54. PubMed ID: 9739932
    [No Abstract] [Full Text] [Related]

  • 4. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
    Cardiello P, Srasuebkul P, Hassink E, Mahanontharit A, Samor T, Ruxrungtham K, Lange J, Cooper D, Phanuphak P.
    HIV Med; 2005 Mar 15; 6(2):122-8. PubMed ID: 15807718
    [Abstract] [Full Text] [Related]

  • 5. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F, Adda N, Schneider V, Jacomet C, Salhi Y, Rozenbaum W.
    Clin Infect Dis; 1999 May 15; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Boonyaprawit P.
    Antivir Ther; 2005 May 15; 10(8):911-6. PubMed ID: 16430196
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
    AIDS; 1998 Oct 01; 12(14):F151-60. PubMed ID: 9792371
    [Abstract] [Full Text] [Related]

  • 9. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
    Eiros Bouza JM, Ortega Lafont M, Ortiz de Lejarazu R, Bachiller Luque P, de Luis Román DA.
    An Med Interna; 2003 May 01; 20(5):239-42. PubMed ID: 12831297
    [Abstract] [Full Text] [Related]

  • 10. A patient's guide to protease inhibitors.
    Elperin A, Sax P.
    AIDS Clin Care; 1996 Oct 01; 8(10):83-4. PubMed ID: 11363988
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ddI and d4T plus protease inhibitors.
    GMHC Treat Issues; 1996 Nov 01; 10(11):8-9. PubMed ID: 11364012
    [Abstract] [Full Text] [Related]

  • 14. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA, Jurriaans S, Weverling GJ, Burger DM, Hoetelmans RM, Roos MT, Maas J, Miedema F, Reiss P, Portegies P, de Wolf F, Lange JM.
    Antivir Ther; 2001 Mar 01; 6(1):55-62. PubMed ID: 11417762
    [Abstract] [Full Text] [Related]

  • 15. Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
    Eshleman SH, Krogstad P, Jackson JB, Wang YG, Lee S, Wei LJ, Cunningham S, Wantman M, Wiznia A, Johnson G, Nachman S, Palumbo P.
    J Infect Dis; 2001 Jun 15; 183(12):1732-8. PubMed ID: 11372025
    [Abstract] [Full Text] [Related]

  • 16. Cure or control of HIV/AIDS?
    Collins DO, Sakamoto A.
    Med Hypotheses; 1997 Jun 15; 48(6):489-90. PubMed ID: 9247891
    [No Abstract] [Full Text] [Related]

  • 17. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct 15; 13(73):180-2. PubMed ID: 15499699
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.
    de Mendoza C, Soriano V, Pérez-Olmeda M, Rodés B, Casas E, González-Lahoz J.
    J Hum Virol; 1999 Oct 15; 2(6):344-9. PubMed ID: 10774551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.